What is it about?
ABSTRACT Aims: To conduct a review of the literature concerning existing methods to detect alkaline phosphatase (ALP) in human serum and to examine the dietary factors that modulate ALP-intestinal isoenzyme (IAP) activity, in light of new findings about its additional functions. Method: Alkaline phosphatase (ALP) testing was used to detecting liver diseases and bone disorders. When the liver is impaired, damaged hepatocytes release increased amounts of ALP into the blood. Results: If the results of other liver tests, such as for bilirubin, aspartate aminotransferase (AST), and/or alanine aminotransferase (ALT), are high, usually the ALP is usually coming from the liver. If it is not clear from the patient’s signs and symptoms or from the results of other routine tests whether the high ALP originates from is due to liver or bone, then a test for ALP isoenzymes, produced by different types of tissue, may be necessary to distinguish the sources of APL. There are 4 gene ALP families: 1), intestinal (found on chromosome 2); placental (2); germ cell (3) and non–tissue-specific (4). The tissue nonspecific isoenzyme includes the common serum forms of ALP from bone and liver. Discussion of Testing Methods: The total ALP activity is typically measured colorimetrically using the p-nitrophenol method. ALP isoenzyme levels can be measured via a method described by the Japanese Society of Clinical Chemistry, in which the ALP isoenzymes are separated electrophoretically with Titan III supporting media. A mouse monoclonal antibody specific to the bone alkaline phosphatase (BAP) is available and, has been adapted to an immunoassay to detection this enzyme. Conclusion: Isoenzyme testing is crucial before an accurate diagnosis can be made; this option should be considered when the signs and symptoms of certain diseases fail to provide a clear answer that explains clinical or laboratory features in acute or chronic diseases. Keywords: alkaline phosphatase, bone alkaline phosphatase, neutrophil alkaline phosphatase, tissue-nonspecific alkaline phosphatase, intestinal alkaline phosphatase.
Featured Image
Photo by John Westrock on Unsplash
Why is it important?
ALP is found in all human tissues, and is particularly is concentrated in liver, bone, kidney, intestines, placenta, and in mature or immature leukocytes, as neutrophil ALP (NAP). This enzyme exists in multiple forms; some are coded on specific genetic loci, whereas others (such as isoforms enzymes) differ only by post-translational modification (primary glycosylation) [1]. Measurement of ALP isoenzymes may be helpful in determining which organ and tissues contain elevated ALP [2]. Based on the results of studies of hypophosphatasia, a systemic skeletal disorder resulting from a tissue-nonspecific ALP (TNAP) deficiency, TNAP has been suggested to be indispensable for bone mineralization [3]. Results suggest that variation in TNAP may be an important determinant of age-related bone loss in humans and that the phosphate metabolism pathway may provide a novel target for the prevention and treatment of osteoporosis. Four isoenzymes can be distinguished in the human body: the placental-specific ALP (PLAP), germ cell–specific ALP, ALP-intestinal isoenzyme (IAP) and TNAP. The production of TNAP is strongest in the liver, kidney, and bones [4]. Alternately, it has been suggested that TNAP could be a plasma membrane transporter for inorganic phosphate; also, TNAP is known to be a marker of osteoblast differentiation. However, there have been no previous reports, to our knowledge, of cell-surface expression of TNAP by immature cells
Perspectives
Read the Original
This page is a summary of: Alkaline Phosphatase Isoenzymes and Leukocyte Alkaline Phosphatase Score in Patients with Acute and Chronic Disease: A Brief Review, British Journal of Medicine and Medical Research, January 2014, Sciencedomain International,
DOI: 10.9734/bjmmr/2014/3309.
You can read the full text:
Resources
References
References [1. Alkaline phosphatase isoenzymes. (SydPath), The Pathology Service of St Vincent’s Hospital Sydney, Pathology Links. Accessed 30 January 30, 2013. Available: www.syndpath.com.au. [2]Moss DW. Alkaline phosphatase isoenzymes. Clin Chem 1982; 28: 2007-2016. [3] Goseki-Sone M, Sogabe N, Fukushi-Irie M, Mizoi L, Orimo H, Suzuki T, et al. Functional analysis of the single nucleotide polymorphism (787T>C) in the tissue-nonspecific alkaline phosphatase gene associated with BMD. J Bone Miner Res. 2005; 20 (5):773-782. [4] Miura M, Sakagishi Y, Hata K, Komoda T. Differences between the sugar moieties of liver- and bone-type alkaline phosphatases: a re-evaluation. Ann Clin Biochem 1994; 31: 25-30. [5] Sobiesiak M, Sivasubramaniyan K, Hermann C, Tan C, Örgel M, Treml S, et al. The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev 2010; 19: 669-677. [6] Karlsson A, Khalfan L, Dahlgren C, Stigbrand T, Follin. Neutrophil alkaline phosphatase activity increased in bacterial infections is not associated with a general increase in secretory vesicle membrane components. Infect Immun. 1995; 63: 911-916. [7] Van Hoof VO, De Broe ME. Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Clin Lab Sci 1994; 31: 197-293. [8] Kress C. Bone alkaline phosphatase, methods of quantitation and clinical utility. J Clin Ligand Assay. 1998; 21: 139-148. [9] Bianco P, Gehron Robey P, Saggio I, Riminucci M. “Mesenchymal” stem cells in human bone marrow (skeletal stem cells):. A critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther 2010; 21: 1057-1066. [10] Hessle L, Johnson AK, Anderson CH, Narisawa S, Sali A, Goding JW, et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A. 2002; (99):(14): 9445-9449. [11] Bianco P. Back to the future: moving beyond “mesenchymal stem cells”. J Cell Biochem 2011; 112(7): 1713-1721. [12] Agnieszk A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J. Cell. Physiol 2009; 218: 237-245. [3] Oomar U, Hirano K, Stigbrand T. Serum levels of human alkaline phosphatase isozymes in relation to blood groups. Clin Chim Acta 1991; 203: 305-313. [14] Nakata N, Tozawa T. ABO blood groups-dependent reference intervals for serum alkaline phosphatase isozymes and total activity in individuals 20-39 years of age. Rinsho Byori Japanese 1995; 43: 508-512. [15] Lallès J-P. Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 2010; 68(6): 323-332. [16] Lange PH, Millan JL, Stigbrand T, Vessella RL, Ruoslahti E, Fishman WHet al. Placental alkaline phosphatase as a tumor marker for seminoma. Cancer Res 1982; 42: 3244-3247. [17] Tietz WN, Rinker DA, Burtis C, Duncan P et al. Transferability studies for the AACC reference method and the IFCC method forof measurement of alkcaline phosphatase activity. Clin Chem. 1984; 30(5): 704-7068. [18] Masakazu I, Jinko I, Akihiro T, Masato M; Japanese Society of Clinical Chemistry. Recommendation methods for the measurement of human serum enzyme activity Alkaline phosphatase. Jpn J Clin Chem 2004; 33(Supp l):78a-96a. [19] Kaplow LS. Leukocyte alkaline phosphatase cytochemistry: Applications and methods. Ann NY Acad Sci 1989;155: 911-947. [20] Dufour RD, Lott AJ, Nolte SF, Gretch RD, Koff RS, Seeff BL. Laboratory guidelines for screening, diagnostics and monitoring of hepatic injury, Vol. 12. The National Academy of Clinical Biochemistry, Washington DC; 2000. [21] Tietz WN. Clinical guide to laboratory tests, 2d edition Philadelphia: W. B. Saunders; 1990. [22] Porter RS, ed. The Merck Manual of Diagnosis and Therapy, 19th ed. West Point (PA): Merck Sharp & Dohme Corp.; 2011. [23] Peracino A, Casttelleto G, Eds. Riegel H, Pietsch M, Lommel H, Albath W. Italian Vademecum of Laboratory Medicine. Verlang, Milano 1995. [24] Udristioiu A. Bioenergetics of Malign and Normal Cells. Edit. Academic Brancusi, Romania, Targu Jiu 2002. [25] Lab Tests Online (2011). American Association for Clinical Chemistry (AACC) Web site. Accessed 1 August 2013. Available: http://www.aacc.org/resourcecenters/LTOPresence/Pages/default.aspx#. [26] Lum G. Significance of low serum alkaline phosphatase activity in a predominantly adult male population. Clin Chem 1995; 41: 515-518. [27] Kato Y, Yamamoto M, Ikegami J, Okumura S, et al. A possible mechanism of increase in serum alkaline phosphatase activity in rats given granulocyte colony-stimulating factor. Exp Anim 1996; 45: 23-32. [28] Fossa SD, Poulsen JP, Aaserud A. Alkaline phosphatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer. Lancet 1992; 340: 1544. [29] Tsuruta T, Tani K, Hoshika A, Asano Set, et al. Alkaline phosphatase, defensin gene expression and effect of myeloid cell growth factors in normal and leukemic cells. Leuk Lymphoma 1999; 32: 237-247. Authors’ Disclosures of Potential Conflicts of Interest I confirm that my Manuscript “Hematological and Metabolically Aspects of Laboratory Medicine-a new review” is an original research and I have contributed as single author to the intellectual content of this paper. Also I have met the following 3 requirements for every chapter of Book, 1-15: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article. Authors’ Disclosures of Potential Conflicts of Interest: No authors declared any potential conflicts of interest for chapter 6 “Alkaline Phosphatase Isoenzymes and Leukocyte Alkaline Phosphatase Score in Patients with Acute and Chronic Disease: A Brief Review’. Statement of Founds: [1]. Grant/Funding support-not applicable. [2]. Financial disclosures- not applicable. [3]. Acknowledgements- not applicable. Author, Aurelian Udristioiu, Emergency County Hospital Targu Jiu, Clinical Laboratory, Fax; 40253210432, Phone; 40723621414, E-mail; aurelianu2007@yahoo.com
Women Heakth International Sunnitt to Nice, France, in 30-31 Mai/2019
https://link.growkudos.com/1klgxjwx7gg Dear colleagues Keeping the tradition of every year, we invite you to attend the 3rd International Conference on Women Health and Breast Cancer (Women Health-2019), which will be held during May 30-31, 2019 at Nice, France, The themes to be discussed at the "Women Health and Breast Cancer" session are professional experiences that can be shared with all workplace colleagues and will be needed to continually improve work by increasing the level of the quality system of the medical act. The events have topics in Conference Sessions as "Breast Cancer, present and perspective, Reproductive Health, Gynecology and Obstetrics, Heart Disease in Women, Nutritional Supplements, Diabetes and Metabolism, Kidney Disease in Women, Lung Cancer, Alzheimer's disease, Endocrine pathology in the diversity of cancer tumors and subjects with variation " The full themes of Congress aim to develop and evaluate strategies to prevent metabolic diseases, focusing on patho-physiology of diseases. All of these are designed to develop an interactive climate to discuss the latest scientific breakthroughs in the field of clinical medicine, " You're welcome! President of Conference Dr. Aurelian Udriştioiu https://scientificfederation.com/womens-health-2019\ .
Contributors
The following have contributed to this page